Get Permission Pranav, Vasugi, Padmavathy, Dhanabal, and Arun: Demographic profile of thyroid malignancies in a tertiary care centre in South India


Introduction

The thyroid gland is a crucial endocrine gland in the body, secreting thyroxine, a hormone that plays a significant role in metabolic processes. Thyroid malignancies make upto 2.1% of all cancers, making them the most common type of endocrine cancer. The first thyroid cancer case was reported in the year 1811. The disease was first described by William Stewart Halsted, an American surgeon, in the late nineteenth century. The Indian Council of Medical Research (ICMR) established the National Cancer Registry Program, and has collected the data of more than 3,00,000 cancer cases between1984 and 1993. The data showed 5614 cases of thyroid cancer, which included 3617 females and 2007 males. Six centers were involved in the studies which included Mumbai, Delhi, Thiruvananthapuram, Dibrugarh, Chandigarh, and Chennai. Thiruvananthapuram had the highest relative incidence of cases of thyroid cancer 1.99% among males and 5.71% among females showing a female prepondarance. This infers that incidence of thyroid cancers is higher in coastal areas than in inland areas. The high risk factors for thyroid malignancies include radiation exposure and chromosomal alterations while low risk factors include iodine in diet, increased BMI, environmental pollutants etc.

Since the increase in incidence have been observed for small and localized tumors having a significant increased rate of survival, the incidence trends are attributed to overdiagnosis, in view of widespread use of diagnostic radioimaging and more sensitive diagnostic modalities. Increased incidence of large and advanced thyroid malignanciess, as well as thyroid cancer mortality, suggest that etiological factors play a significant role to rising incidence of the disease, albeit to a lesser extent than overdiagnosis.

Histologically, thyroid tissue consists of thyroid follicles, along with parafollicular C-cells. Thyroid follicular cells are associated with two major groups of cancers: differentiated (papillary and follicular) and undifferentiated (anaplastic) carcinomas. Parafollicular C-cells, which originate from the neural crest, lead to the development of medullary thyroid carcinomas. The most common subtype among thyroid cancers is papillary, accounting for 70-80% of all cases. It is important to note that the prevalence of thyroid malignancies varies significantly based on geographical location. Some European countries, such as Denmark and Netherlands, have low rates, while areas like Hawaii experience higher rates. Furthermore, the incidence of thyroid cancer exhibits unique variations related to age, sex, and ethnicity.

Immunohistochemical (IHC) markers of thyroid malignancies can be divided into two major subtypes: those related to the cell types and those related to the type of pathology. The most important markers in the first category are thyroglobulin and TTF-1 for follicular cells, and calcitonin, CEA, and chromogranin for parafollicular C cells. Markers in the second category are primarily directed at papillary carcinoma and includes galectin 3, S-100 protein, cytokeratin 19, high-molecular weight keratin (identifiable with antibody 34betaE12), HBME-1 and p27kip1.

Given these considerations, this study aims to investigate the epidemiological and morphological patterns of selected cases of thyroid neoplasms in a South Indian tertiary care centre across a 8 year period. It will focus on factors such as age, sex, histological subtype, TNM staging, the number of thyroidectomies performed and associated complications with an insight into the recent immunohistochemical updates of thyroid carcinomas.

Materials and Methods

All cases of thyroid carcinomas reported in the department of Pathology at a tertiary care center in South India from January 2016- December 2020 were included in this study. Few cases have been confirmed through the intraoperative frozen section which were clinically and radiologically skeptical. The demographic profile, patient details and other relevant information were obtained from the medical records section. Pathology reports of the included cases were retrieved and analyzed for histopathological subtype and TNM staging. Institutional ethical clearance CSP/21/AUG/97/407 was obtained prior to the start of the study.

A structured proforma was designed to record the clinical details, which included age, gender, presenting symptoms, site of the tumour, type of surgery, histopathological subtype and TNM staging and other laboratory investigations and treatment modalities. The patients were categorized according to their age (>30, 30-50, and <50 years). Histopathological slides belonging to all the study cases were retrieved and analysed.The grading and staging of excised specimens were based on the AJCC cancer staging protocol. Variables following normal distribution were expressed as mean (standard deviation), and variables that followed skewed distribution were expressed as median.

Results

Out of the 98 cases of thyroid carcinoma included in the study, 16 cases (16.3%) were below 30 years of age, 44 cases (44.9%) were 30-50 years of age and 38 cases (38.8%) were above 50 years of age (Table- 1) The mean age was 45.78. Female preponderance was noted, with 66 cases (67.3%) being females and 32 cases (32.65%) were males (table 2). The histopathology results revealed 90 cases (91.8%) to be papillary carcinoma, 1 case(1.02%) of medullary carcinoma, 1 case(1.02%) of Insular carcinoma, 5 cases(5.102%) of follicular carcinoma and 1 case(1.02%) of anaplastic carcinoma. Most of the cases were classified as T1 tumours (45.91%) under the TNM classification. 24 cases (24.49%) were graded as N1 (Metastasis to regional nodes). 3 cases (3.06%) exhibited distant metastasis. Majority of the cases (71.42%) were samples from a total thyroidectomy (Table- 3). The age distribution of different histological subtypes were tabulated in Table- 4. Comparison of age range and mean age of total thyroid carcinomas with other studies were mentioned in Table -5. The Histopathological images of various histological types of thyroid carcinomas are depicted in figures 1-5.

Graph 1

Gender-wise distribution of cases

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/5a8c4b2b-167e-44f2-ad4b-04bcf46b83cd-uimage.png

Graph 2

Gender-wise distribution of cases

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/db5bf475-6de8-4800-bcb8-9c1abf10f40c-uimage.png

Table 1

Demographic profile

Variables

Entity

Number of Cases

Percentage

Age

<30

16

16.3265306

30-50

44

44.8979592

>50

38

38.7755102

Mean Age

45.78

Gender

Male

32

32.6530612

Female

66

67.3469388

Histopathology

Papillary Ca

90

91.8367347

Medullary Ca

1

1.02040816

Insular Ca

1

1.02040816

Follicular Ca

5

5.10204082

Anaplastic Ca

1

1.02040816

Tumour size

T1(Tumor ≤ 2 cm in greatest dimension limited to the thyroid)

45

45.9183673

T1a(Tumor ≤ 1 cm in greatest dimension limited to the thyroid)

26

26.5306122

T1b(Tumor > 1 cm but ≤ 2 cm in greatest dimension limited to the thyroid)

19

19.3877551

T2(Tumor > 2 cm but ≤ 4 cm in greatest dimension limited to the thyroid)

34

34.6938776

T3(Tumor > 4 cm limited to the thyroid or gross extrathyroidal extension invading only strap muscles)

19

19.3877551

T3a(Tumor > 4 cm limited to the thyroid)

19

19.3877551

T3b(Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles) from a tumor of any size)

0

0

T4(Includes gross extrathyroidal extension into major neck structures)

0

0

Extent of nodal involvement

Nx(Regional lymph nodes cannot be assessed)

55

56.122449

N0(No evidence of regional lymph node metastasis)

19

19.3877551

N1(Metastasis to regional nodes)

24

24.4897959

N1a: (Metastasis to level VI or VII (pretracheal, paratracheal, prelaryngeal / Delphian or upper mediastinal) lymph nodes; this can be unilateral or bilateral disease)

8

8.16326531

N1b*: Metastasis to unilateral, bilateral or contralateral lateral neck lymph nodes (levels I, II, III, IV or V) or retropharyngeal lymph nodes)

16

16.3265306

Distant metastasis

M0(No distant metastasis)

95

96.9387755

M1(Distant metastasis)

3

3.06122449

Type of Surgery

Hemithyroidectomy

16

16.3265306

Subtotal/Near-total thyroidectomy

11

11.2244898

Total thyroidectomy

70

71.4285714

Completion thyroidectomy

1

1.02040816

Table 2

Age groups of specific subtypes

Subtype

Age Group

<30

30-50

>50

Total Cases

Papillary

16(17.78%)

39(43.33%)

35(38.89%)

90

Anaplastic

0

1(100%)

0

1

Medullary

0

0

1(100%)

1

Insular

0

0

1(100%)

1

Follicular

0

4(80%)

1(20%)

5

Table 3

Comparison of age range and mean age of total thyroid carcinomas

Entity

Cherit et al

Huber et al

Ponniah et al

Present Study

Age Range

21-76

19-84

10-85

18-85

Mean Age

43.8

44

34.5

45.41

Figure 1

Histology of papillary carcinoma, classic subtype (H&E x 200x)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/08087fba-dceb-4cb4-9dc0-c6f389ae17f0-uimage.png

Figure 2

Histology of Follicular carcinoma (H&E x 200x)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/026906dc-af1f-4c29-871a-fe7b5001ff6c-uimage.png

Figure 3

Histology of poorly differentiated carcinoma (H&E x 200x)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/3605be4e-090d-4157-b4fd-10a27ba9a838-uimage.png

Figure 4

Histology of Medullary carcinoma thyroid (H&E x 200x)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/ea4b04aa-00d8-41a2-b3dc-3020905c49d7-uimage.png

Figure 5

Histology of Anaplastic carcinoma thyroid (H&E x 200x)

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/411344de-b500-4687-9a04-d887a565c666/image/b9e13163-e1dd-4b23-b13a-6158ad0e72e5-uimage.png

Discussion

GLOBOCAN 2020 database of cancer incidence and mortality by the WHO International agency for research on cancer has found that thyroid cancer has been among the ninth cancer incidence worldwide.1, 2 In 2023, an estimated 43,720 adults (12,540 men and 31,180 women) in the United States will be diagnosed with thyroid cancer. Women are 3 times more likely to have thyroid cancer than men, our study also recorded a female preponderance of 68.37%.3, 4, 5

Age range of our study was 18-85yrs with mean age of 45.78 years, which was found to be concordant to two other studies from our review of literature. Comparison with another study from South India (Ponniah et al.) showed that there was a higher incidence of thyroid carcinoma in a relatively older age group.6

Thyroid cancer can occur at any age, but the risk peaks earlier for women (3rd and 6th decades) than men (7th and 8th decades). In our study the mean age affected was 43.66 years for females and 49.19 years for males. So in our study group, the incidence of thyroid cancer was much earlier in females as expected. Incidence of thyroid carcinomas is three times more in virtually all geographic locations in females than in males. However the reasons are unclear. Several studies have attributed that female sex hormones play a role in the etiology of thyroid malignancies. Pregnancy and hormonal treatment have also been associated with thyroid malignancies among females. The hormone-related factors probably act as promoters of tumor growth and proliferation.7, 8, 9

Iodine has an essential role in production and regulation of thyroid hormones. Both deficiency and excess intake of iodine are considered to be risk factors of thyroid cancer. Chronic hyper secretion of Thyroid stimulating hormone (TSH) is associated with thyroid follicular cell hyperplasia and hypertrophy and this association leads on to an increased risk of neoplastic transformation. Long term intake of excessive amounts of iodine can also affect the functioning of the thyroid follicular epithelial cells which eventually may elevate hormone levels.

In the literature, numerous histopathological variants of thyroid carcinoma have been described, each with distinct behaviors. According to various studies, classical papillary carcinoma is the most prevalent variant,10 followed by papillary microcarcinoma and the follicular variant of papillary carcinoma, in descending order of frequency. In our study, we also found classical papillary carcinoma to be the most common(91.84%), followed by the follicular variant of papillary carcinoma (5.1%). Insular, anaplastic and medullary carcinomas were the least commonly encountered types in our research.11, 12, 13, 14

Histologically, classic PAPCA can present as a fairly circumscribed lesion limited to thyroid with papillary architecture and cells having the characteristic nuclear features including nuclear enlargement, clearing, grooving, overlapping, intranuclear cytoplasmic inclusions etc. Follicular carcinomas usually have a thick capsule with solid and trabecular arrangement of thyroid follicles and evident capsular and vascular invasion. Medullary carcinomas arising from the C-cells have propensity for multifocality and usually have round, plasmacytoid, polygonal or spindled and arranged in nests, cords or follicles. Numerous lymphocytes and plasma cells may be seen admixed. Occasionally amyloid may also be noted. Insular and anaplastic types are high grade with high propensity to invade adjacent structures.

Symptoms like hoarseness, dysphagia, and airway obstruction are occasionally associated with thyroid carcinoma. The presence of a hard, fixed nodule during a physical examination can raise suspicion of malignancy. But PAPCA can remain asymptomatic and present with extra thyroid lesions or evidence of metastasis too. One clinical challenge lies in determining which asymptomatic thyroid nodules warrant surgical intervention. Factors such as patient age, sex, and history of irradiation can offer some clues but only affect the likelihood of malignancy. Thyroid function tests typically appear normal in thyroid cancer patients and are valuable for excluding other disorders. Ultrasound can identify cystic lesions, which, if smaller than 4 cm and without internal echoes, are usually benign. Fine-needle aspiration biopsy is the most cost-effective and accurate method for diagnosing papillary, medullary, and anaplastic thyroid cancers. However, it isn't particularly helpful in distinguishing between follicular or Hurthle cell adenomas and carcinomas.15, 16, 5

Conclusion

In our demographic study, we observed that thyroid carcinomas tend to peak in incidence during the fourth decade of life, with a higher prevalence among females. The majority of cases in our study were identified as papillary carcinomas. The TNM staging for all the cases were analyzed. Most of the cases were samples from a total thyroidectomy. A thorough review of literature and appropriate comparisons were also done. As a result, a complete demographic profile regarding thyroid carcinomas in our tertiary health care centre was obtained and also helps us understand how the trends in our hospitals differ when compared to similar studies from other centre. This understanding is essential for making informed decisions about the most suitable treatment approaches, predicting patient prognosis, and assessing clinical outcomes.

Human Subjects

Consent was obtained or waived by all participants in this study. Sri Ramachandra Institutional Ethics Committee issued approval CSP/21/AUG/97/407. The tissue in paraffin blocks can be subjected to research purposes since SRIHER is an academic institution. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

Source of Funding

All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Conflicts of Interest

In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Other Relationships

All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

References

1 

M Pizzato M Li J Vignat M Laversanne D Singh CL Vecchia The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020Lancet Diabetes Endocrinol202210426472

2 

CE Barrows JM Belle A Fleishman CC Lubitz BC James Financial burden of thyroid cancer in the United States: an estimate of economic and psychological hardship among thyroid cancer survivorsSurgery2020167237884

3 

SA Nejadghaderi SS Moghaddam S Azadnajafabad N Rezaei N Rezaei SM Tavangar Burden of thyroid cancer in North Africa and Middle East 1990–2019Front Oncol202212955358

4 

M Azangou-Khyavy SS Moghaddam N Rezaei Z Esfahani N Rezaei S Azadnajafabad National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019Sci Rep202212113231

5 

L Enewold K Zhu E Ron AJ Marrogi A Stojadinovic GE Peoples Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005Cancer Epidemiol Biomark Prev198018378491

6 

A Ponniah LM Ilias P Vijayan BA Mohammed T Deeshma AS Nalakath Papillary carcinoma thyroid - A 11 year epidemiological study with histopathological correlation in a tertiary care centre in South Malabar Region in Kerala, IndiaJ Pathol Nepal20155798805

7 

MA Rossing LF Voigt KG Wicklund JR Daling Reproductive factors and risk of papillary thyroid cancer in womenAm J Epidemiol2000151876572

8 

T Haselkorn SL Stewart PL Horn-Ross Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer studyCancer Epidemiol Biomarkers Prev200312214450

9 

LC Sakoda PL Horn-Ross Reproductive and Menstrual History and Papillary Thyroid Cancer Risk The San Francisco Bay Area Thyroid Cancer StudyCancer Epidemiol Biomarkers Prev2002111517

10 

Y Deng H Li M Wang N Li T Tian Y Wu Global burden of thyroid Cancer from 1990 to 2017JAMA Netw Open202036e208759

11 

N Chagi I Bombil A Mannell The profile of thyroid cancer in patients undergoing thyroidectomy at Chris Hani Baragwanath Academic HospitalS Afr J Surg20195735462

12 

EM Der Follicular thyroid carcinoma in a country of Endemic Iodine Deficiency (1994-2013)J Thyroid Res2018201815

13 

E Der Y Tetty R Gyasi E Wiredu Trends in thyroid malignancies in Accra Ghana: a retrospective histopathological review in the Department of Pathology (1994–2013), Korle-Bu Teaching HospitalJ Cancer Sci Clin Oncol199451101

14 

JB Kakamba N Sabbah P Bayauli M Massicard J Bidingija A Nkodila Thyroid cancer in the Democratic Republic of the Congo: frequency and risk factorsAnn Endocrinol (Paris)202182660612

15 

N Pandeya DS Mcleod K Balasubramaniam PD Baade PH Youl CJ Bain Increasing thyroid cancer incidence in Queensland, Australia 1982-2008 - true increase or overdiagnosis?Clin Endocrinol (Oxf)201684225764

16 

B Larijani S Aghakhani V Haghpanah A Mosavi-Jarrahi M H Bastanhagh Review of thyroid Cancer in IranAustral-Asian Journal of Cancer200544199203



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 27-05-2024

Accepted : 11-06-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/ 10.18231/j.ijpo.2024.029


Article Metrics






Article Access statistics

Viewed: 722

PDF Downloaded: 261